161 related articles for article (PubMed ID: 26639107)
1. Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle.
Hermes Tde A; Macedo AB; Fogaça AR; Moraes LH; de Faria FM; Kido LA; Cagnon VH; Minatel E
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):259-67. PubMed ID: 26639107
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine.
Moraes LH; de Burgos RR; Macedo AB; de Almeida Hermes T; de Faria FM; Minatel E
Biol Trace Elem Res; 2015 Sep; 167(1):115-20. PubMed ID: 25762099
[TBL] [Abstract][Full Text] [Related]
3. Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice.
Tonon E; Ferretti R; Shiratori JH; Santo Neto H; Marques MJ; Minatel E
Nutrition; 2012 Jun; 28(6):686-90. PubMed ID: 22189191
[TBL] [Abstract][Full Text] [Related]
4. Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
Mâncio RD; Hermes TA; Macedo AB; Mizobuti DS; Rupcic IF; Minatel E
PLoS One; 2017; 12(8):e0182449. PubMed ID: 28787441
[TBL] [Abstract][Full Text] [Related]
5. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol attenuates oxidative stress and apoptosis in the quadriceps muscle of the dystrophic mouse experimental model.
Hermes TA; Mâncio RD; Mizobutti DS; Macedo AB; Kido LA; Cagnon Quitete VHA; Minatel E
Int J Exp Pathol; 2023 Feb; 104(1):13-22. PubMed ID: 36565167
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice.
de Senzi Moraes Pinto R; Ferretti R; Moraes LH; Neto HS; Marques MJ; Minatel E
Clin Nutr; 2013 Jun; 32(3):472-5. PubMed ID: 22727548
[TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.
Messina S; Altavilla D; Aguennouz M; Seminara P; Minutoli L; Monici MC; Bitto A; Mazzeo A; Marini H; Squadrito F; Vita G
Am J Pathol; 2006 Mar; 168(3):918-26. PubMed ID: 16507907
[TBL] [Abstract][Full Text] [Related]
10. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
Mok E; Constantin B; Favreau F; Neveux N; Magaud C; Delwail A; Hankard R
Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
12. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells.
Moraes LH; Bollineli RC; Mizobuti DS; Silveira Ldos R; Marques MJ; Minatel E
Redox Rep; 2015 May; 20(3):109-15. PubMed ID: 25361473
[TBL] [Abstract][Full Text] [Related]
13. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study.
Nakae Y; Hirasaka K; Goto J; Nikawa T; Shono M; Yoshida M; Stoward PJ
Histochem Cell Biol; 2008 Apr; 129(4):489-501. PubMed ID: 18264714
[TBL] [Abstract][Full Text] [Related]
15. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
18. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
Hnia K; Hugon G; Rivier F; Masmoudi A; Mercier J; Mornet D
Am J Pathol; 2007 Feb; 170(2):633-43. PubMed ID: 17255331
[TBL] [Abstract][Full Text] [Related]
19. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
20. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
